Home » Topics » BioWorld Science

BioWorld Science
RSS

Pivotal study of KP-415 in children with ADHD meets primary efficacy endpoint

July 12, 2018

Galapagos, AbbVie discover CFTR modulators

July 12, 2018

National Center for Global Health and Medicine, Kumamoto University and Yamasa patent antivirals

July 12, 2018

Amgen describes new beta-secretase inhibitors

July 12, 2018

OG-716, a lantibiotic that is active against Clostridium difficile infections

July 12, 2018

Argenx presents phase II data for ARGX-113 in myasthenia gravis

July 12, 2018

Advaxis withdraws conditional MAA for axalimogene filolisbac, advances ADXS-HOT program

July 12, 2018

Recursion set to begin phase I study of AI/ML-based drug candidate, REC-994

July 12, 2018

First patient dosed in phase II study of CV-301 plus nivolumab in metastatic colorectal cancer

July 12, 2018

Tegsedi approved in the E.U. for the treatment of hATTR

July 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...